TARAH SELLNER: Open Payments
NPI 1659865533 · PUEBLO, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,591 in 100 payments from 23 companies in 2025. Trend: 2023 $1,620 · 2024 $1,260 · 2025 $1,591
Food & beverage: $1,591
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $232 |
| AstraZeneca Pharmaceuticals LP | 8 | $162 |
| Novo Nordisk Inc | 14 | $157 |
| GlaxoSmithKline, LLC. | 15 | $156 |
| PFIZER INC. | 12 | $149 |
| ABBVIE INC. | 8 | $148 |
| Novartis Pharmaceuticals Corporation | 3 | $78 |
| Xeris Pharmaceuticals, Inc. | 3 | $62 |
| Aimmune Therapeutics, Inc. | 3 | $60 |
| Amgen Inc. | 4 | $59 |
Products named: CAPLYTA, NURTEC ODT, Ozempic, LEQVIO, UBRELVY, SHINGRIX, ZENPEP, TRELEGY ELLIPTA.
Industry payments across CO — which companies pay providers there.
